FDA.reportPublic FDA data

SAXAGLIPTIN HYDROCHLORIDE

Substance profile for UNII Z8J84YIX6L, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for SAXAGLIPTIN HYDROCHLORIDE
Structure render from PubChem CID 49800073

Substance Identity#

UNII
Z8J84YIX6L
Preferred term
SAXAGLIPTIN HYDROCHLORIDE
Registry number
709031-78-7
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
C18H25N3O2.ClH
Chemical structure for SAXAGLIPTIN HYDROCHLORIDE
Structure render from PubChem CID 49800073

Chemical And Database Identifiers#

SMILES
Cl.N[C@H](C(=O)N1[C@H]2C[C@H]2C[C@H]1C#N)C34CC5CC(CC(O)(C5)C3)C4
RxCUI
1043560
PubChem
49800073
NCIt
C81702
INN ID
0

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
PubChem Compound49800073pubchem.ncbi.nlm.nih.gov/compound/49800073
RxNorm1043560mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=1043560
NCI ThesaurusC81702ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C81702
FDA Substance Registration SystemZ8J84YIX6Lprecision.fda.gov/uniisearch/srs/unii/Z8J84YIX6L

DailyMed Socrata Ingredients#

DailyMed label, SPL version table
DailyMed labelSPL version
These highlights do not include all the information needed to use ONGLYZA safely and effectively. See full prescribing information for ONGLYZA. ONGLYZA (saxagliptin) tablets Initial U.S. Approval: 20093
ONGLYZA (SAXAGLIPTIN) TABLET, FILM COATED [E.R. SQUIBB & SONS, L.L.C.]9
KOMBIGLYZE XR (SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE) TABLET, FILM COATED, EXTENDED RELEASE [E.R. SQUIBB & SONS, L.L.C.]7
ONGLYZA (SAXAGLIPTIN) TABLET, FILM COATED [ASTRAZENECA PHARMACEUTICALS LP]4
KOMBIGLYZE XR (SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE) TABLET, FILM COATED, EXTENDED RELEASE [ASTRAZENECA PHARMACEUTICALS LP]3
ONGLYZA (SAXAGLIPTIN) TABLET, FILM COATED [CARDINAL HEALTH]2
ONGLYZA (SAXAGLIPTIN) TABLET, FILM COATED [CARDINAL HEALTH]1